JP2018520095A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018520095A5 JP2018520095A5 JP2017559029A JP2017559029A JP2018520095A5 JP 2018520095 A5 JP2018520095 A5 JP 2018520095A5 JP 2017559029 A JP2017559029 A JP 2017559029A JP 2017559029 A JP2017559029 A JP 2017559029A JP 2018520095 A5 JP2018520095 A5 JP 2018520095A5
- Authority
- JP
- Japan
- Prior art keywords
- ebv
- lpd
- pharmaceutical composition
- configuration
- allogeneic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021070234A JP2021119154A (ja) | 2015-05-12 | 2021-04-19 | Ｔ細胞療法によるエプスタイン−バーウイルス関連リンパ増殖性障害の治療方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562160549P | 2015-05-12 | 2015-05-12 | |
| US62/160,549 | 2015-05-12 | ||
| PCT/US2016/031784 WO2016183153A1 (en) | 2015-05-12 | 2016-05-11 | Methods of treating epstein-barr virus-associated lymphoproliferative disorders by t cell therapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021070234A Division JP2021119154A (ja) | 2015-05-12 | 2021-04-19 | Ｔ細胞療法によるエプスタイン−バーウイルス関連リンパ増殖性障害の治療方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018520095A JP2018520095A (ja) | 2018-07-26 |
| JP2018520095A5 true JP2018520095A5 (enExample) | 2019-11-14 |
| JP7284556B2 JP7284556B2 (ja) | 2023-05-31 |
Family
ID=56027234
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017559029A Active JP7284556B2 (ja) | 2015-05-12 | 2016-05-11 | Ｔ細胞療法によるエプスタイン－バーウイルス関連リンパ増殖性障害の治療方法 |
| JP2021070234A Pending JP2021119154A (ja) | 2015-05-12 | 2021-04-19 | Ｔ細胞療法によるエプスタイン−バーウイルス関連リンパ増殖性障害の治療方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021070234A Pending JP2021119154A (ja) | 2015-05-12 | 2021-04-19 | Ｔ細胞療法によるエプスタイン−バーウイルス関連リンパ増殖性障害の治療方法 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US10568908B2 (enExample) |
| EP (1) | EP3294304B1 (enExample) |
| JP (2) | JP7284556B2 (enExample) |
| KR (1) | KR102666781B1 (enExample) |
| CN (1) | CN107835690A (enExample) |
| AR (1) | AR104598A1 (enExample) |
| AU (1) | AU2016262484B2 (enExample) |
| BR (1) | BR112017024431B1 (enExample) |
| CA (1) | CA2984178C (enExample) |
| CL (1) | CL2017002846A1 (enExample) |
| FR (1) | FR23C1025I2 (enExample) |
| IL (1) | IL255581B (enExample) |
| MX (1) | MX386334B (enExample) |
| NZ (1) | NZ736675A (enExample) |
| PH (1) | PH12017501993A1 (enExample) |
| RU (1) | RU2720245C2 (enExample) |
| WO (1) | WO2016183153A1 (enExample) |
| ZA (1) | ZA201707335B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017203356A1 (en) | 2016-05-25 | 2017-11-30 | The Council Of The Queensland Institute Of Medical Research | Methods of immunotherapy |
| JP7002769B2 (ja) * | 2016-09-16 | 2022-02-04 | ベイラー カレッジ オブ メディスン | ウイルス特異的ｔ細胞の活性化および拡大のためのプラットフォーム |
| US11925663B2 (en) | 2017-10-23 | 2024-03-12 | Atara Biotherapeutics, Inc. | Methods of managing tumor flare in adoptive immunotherapy |
| CN108220237B (zh) * | 2017-12-20 | 2020-11-06 | 中国科学院遗传与发育生物学研究所 | 一种人的nk/t细胞系 |
| WO2019136379A1 (en) * | 2018-01-08 | 2019-07-11 | Atara Biotherapeutics, Inc. | Systems and methods for distributing cell therapies |
| EP3765602A1 (en) | 2018-03-14 | 2021-01-20 | Memorial Sloan Kettering Cancer Center | Methods of selecting t cell line for adoptive cellular therapy |
| AU2020371562A1 (en) * | 2019-10-23 | 2022-06-09 | The Council Of The Queensland Institute Of Medical Research | Adoptive immunotherapy |
| CN118256604B (zh) * | 2024-04-16 | 2024-11-19 | 华中科技大学 | 一种利用人工抗原呈递细胞进行免疫原性肿瘤新抗原筛选与鉴定方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPO784197A0 (en) | 1997-07-10 | 1997-08-07 | Csl Limited | Treatment of nasopharyngeal carcinoma |
| US7163685B2 (en) * | 2003-04-16 | 2007-01-16 | City Of Hope | Human cytomegalovirus antigens expressed in MVA and methods of use |
| JP4824389B2 (ja) * | 2005-10-28 | 2011-11-30 | 株式会社医学生物学研究所 | エプスタイン−バールウイルス感染細胞を特異的に攻撃する細胞傷害性ｔ細胞エピトープペプチド及びその用途 |
| US9738872B2 (en) | 2008-10-30 | 2017-08-22 | Yeda Research And Development Co. Ltd. | Anti third party central memory T cells, methods of producing same and use of same in transplantation and disease treatment |
| EP2611905A4 (en) | 2010-09-01 | 2014-02-12 | Baylor College Medicine | EBV-SPECIFIC CYTOTOXIC T-LYMPHOCYTES FOR THE TREATMENT OF LOCOREGIONAL NANOPHARYNX CARCINOMA (NPC) |
| AU2013260132B2 (en) * | 2012-05-08 | 2017-12-14 | The Johns Hopkins University | Methods and compositions for infusion of transiently engrafting, selected populations of allogeneic lymphocytes to treat cancer |
| EP2909238A4 (en) * | 2012-10-19 | 2016-11-30 | Queensland Inst Med Res | IMPROVED IMMUNOTHERAPY AGAINST HUMAN HERPESVIRUS |
| EP3060059A4 (en) * | 2013-10-25 | 2017-11-01 | Board of Regents, The University of Texas System | Polyclonal gamma delta t cells for immunotherapy |
| AU2015343239B2 (en) * | 2014-11-05 | 2021-06-03 | Memorial Sloan Kettering Cancer Center | Methods of selecting T cell line and donor thereof for adoptive cellular therapy |
| WO2017003763A1 (en) * | 2015-06-27 | 2017-01-05 | Memorial Sloan Kettering Cancer Center | Methods of treating glioblastoma multiforme by t cell therapy |
-
2016
- 2016-05-11 NZ NZ736675A patent/NZ736675A/en unknown
- 2016-05-11 AR ARP160101364A patent/AR104598A1/es unknown
- 2016-05-11 EP EP16724230.4A patent/EP3294304B1/en active Active
- 2016-05-11 BR BR112017024431-4A patent/BR112017024431B1/pt active IP Right Grant
- 2016-05-11 KR KR1020177034692A patent/KR102666781B1/ko active Active
- 2016-05-11 CA CA2984178A patent/CA2984178C/en active Active
- 2016-05-11 JP JP2017559029A patent/JP7284556B2/ja active Active
- 2016-05-11 RU RU2017143151A patent/RU2720245C2/ru active
- 2016-05-11 WO PCT/US2016/031784 patent/WO2016183153A1/en not_active Ceased
- 2016-05-11 US US15/572,557 patent/US10568908B2/en active Active
- 2016-05-11 MX MX2017014257A patent/MX386334B/es unknown
- 2016-05-11 AU AU2016262484A patent/AU2016262484B2/en active Active
- 2016-05-11 CN CN201680039509.4A patent/CN107835690A/zh active Pending
-
2017
- 2017-10-27 ZA ZA2017/07335A patent/ZA201707335B/en unknown
- 2017-11-02 PH PH12017501993A patent/PH12017501993A1/en unknown
- 2017-11-09 IL IL255581A patent/IL255581B/en active IP Right Grant
- 2017-11-10 CL CL2017002846A patent/CL2017002846A1/es unknown
-
2021
- 2021-04-19 JP JP2021070234A patent/JP2021119154A/ja active Pending
-
2023
- 2023-06-14 FR FR23C1025C patent/FR23C1025I2/fr active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018520095A5 (enExample) | ||
| Edelson | Mechanistic insights into extracorporeal photochemotherapy: efficient induction of monocyte-to-dendritic cell maturation | |
| Rao et al. | Anti-PD-1/PD-L1 therapy for infectious diseases: learning from the cancer paradigm | |
| RU2017143151A (ru) | Способы лечения ассоциированных с вирусом эпштейна-барр лимфопролиферативных заболеваний при помощи t-клеточной терапии | |
| Cheever et al. | Therapy with cultured T cells: principles revisited | |
| CN108478780B (zh) | Ctl诱导剂组合物 | |
| IL302514B1 (en) | Improved methods of cell culture for adoptive cell therapy | |
| Kamphorst et al. | Beyond adjuvants: Immunomodulation strategies to enhance T cell immunity | |
| Wei et al. | Effects of tumor irradiation on host T-regulatory cells and systemic immunity in the context of adoptive T-cell therapy in mice | |
| US20180161366A1 (en) | Methods of obtaining mononuclear blood cells and uses thereof | |
| JP2019520823A (ja) | メモリーｔ細胞から作られるベト細胞 | |
| JP2018518527A5 (enExample) | ||
| Koike et al. | Nonmyeloablative chemotherapy followed by T-cell adoptive transfer and dendritic cell-based vaccination results in rejection of established melanoma | |
| JP2018530534A5 (enExample) | ||
| Gea-Banacloche | Immunomodulation | |
| RU2018112526A (ru) | Способы лечения множественной миеломы и плазмоклеточного лейкоза посредством т-клеточной терапии | |
| Jalili et al. | Virus-specific T cells: Promising adoptive T cell therapy against infectious diseases following hematopoietic stem cell transplantation | |
| CA2874431A1 (en) | Method for making t cell population directed to subdominant antigens or epitopes | |
| CN105899219B (zh) | 人类免疫缺陷病毒/获得性免疫缺陷综合症的治疗 | |
| CN105451766A (zh) | 疫苗接种策略 | |
| WO1989005657A1 (en) | Lymphokine activation of cells for adoptive immunotherapy, e.g. of hiv infection | |
| WO2017003763A1 (en) | Methods of treating glioblastoma multiforme by t cell therapy | |
| Rosenthal et al. | J-LEAPS vaccines elicit antigen specific Th1 responses by promoting maturation of type 1 dendritic cells (DC1) | |
| RU2779844C2 (ru) | Вето-клетки, полученные из т-клеток памяти | |
| Lam et al. | Ex Vivo Expanded Multi-Specific Cytotoxic T Lymphocytes Derived from HIV+ Patients and HIV Negative Donors Using GMP Compliant Methodologies Recognize Multiple HIV Antigens and Suppress HIV Replication |